Arigen Pharmaceuticals, Inc.
- Country
- Ownership
- Private
- Employees
- -
- Market Cap
- -
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Study to Compare Efficacy of Topical ARYS-01 (Sorivudine) Cream 3%, Oral Valaciclovir and Combination ARYS-01 Cream 3%/Oral Valaciclovir for Treatment of Herpes Zoster (Shingles)
Phase 2
- Conditions
- Herpes ZosterPostherpetic Neuralgia
- Interventions
- First Posted Date
- 2008-04-03
- Last Posted Date
- 2008-10-07
- Lead Sponsor
- aRigen Pharmaceuticals, Inc.
- Target Recruit Count
- 300
- Registration Number
- NCT00652184
- Locations
- 🇺🇸
ARYS-0701 Site 3, Beverly Hills, California, United States
🇺🇸ARYS-0701 Site 6, Encino, California, United States
🇺🇸ARYS-0701 Site 7, Vista, California, United States
News
No news found